These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1347143)

  • 21. Effect of somatostatin on glucose homeostasis in conscious long-fasted dogs.
    Stevenson RW; Steiner KE; Hendrick GK; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E435-42. PubMed ID: 2889363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperglucagonemia and insulin-mediated glucose metabolism.
    Del Prato S; Castellino P; Simonson DC; DeFronzo RA
    J Clin Invest; 1987 Feb; 79(2):547-56. PubMed ID: 3543054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of amino acids on glucose disposal.
    Boden G; Tappy L
    Diabetes; 1990 Sep; 39(9):1079-84. PubMed ID: 1974539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus.
    Felig P; Wahren J; Sherwin R; Hendler R
    Diabetes; 1976 Dec; 25(12):1091-9. PubMed ID: 992227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of glucose on fuel utilization and glycerol turnover in normal and injured man.
    Jeevanandam M; Grote-Holman AE; Chikenji T; Askanazi J; Elwyn DH; Kinney JM
    Crit Care Med; 1990 Feb; 18(2):125-35. PubMed ID: 2298002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS; Groop LC; Riely CA; DeFronzo RA
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
    Schmitz O
    Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective suppression of hepatic glucose output by human proinsulin in the dog.
    Lavelle-Jones M; Scott MH; Kolterman O; Rubenstein AH; Olefsky JM; Moossa AR
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E230-6. PubMed ID: 2881485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of hepatic autoregulation after carbohydrate overfeeding in normal man.
    Clore JN; Helm ST; Blackard WG
    J Clin Invest; 1995 Oct; 96(4):1967-72. PubMed ID: 7560089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin infusion enhances hepatic glucose production during hyperglucagonemia.
    Meneilly GS; Minaker KL; Elahi D; Rowe JW
    Metabolism; 1988 Mar; 37(3):252-6. PubMed ID: 2893970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic intervention in surgical patients. An assessment of the effect of somatostatin, ranitidine, naloxone, diclophenac, dipyridamole, or salbutamol infusion on energy and protein kinetics in surgical patients using stable and radioisotopes.
    Shaw JH; Wolfe RR
    Ann Surg; 1988 Mar; 207(3):274-82. PubMed ID: 2894205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise-induced fall in insulin: mechanism of action at the liver and effects on muscle glucose metabolism.
    Zinker BA; Mohr T; Kelly P; Namdaran K; Bracy DP; Wasserman DH
    Am J Physiol; 1994 May; 266(5 Pt 1):E683-9. PubMed ID: 7911275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of increasing carbohydrate intake on glucose kinetics in injured patients.
    Elwyn DH; Kinney JM; Jeevanandam M; Gump FE; Broell JR
    Ann Surg; 1979 Jul; 190(1):117-27. PubMed ID: 111634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency.
    Nair KS
    J Clin Endocrinol Metab; 1987 May; 64(5):896-901. PubMed ID: 2881943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
    Shiota M; Galassetti P; Monohan M; Neal DW; Cherrington AD
    Diabetes; 1998 Jun; 47(6):867-73. PubMed ID: 9604861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.
    Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH
    Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation.
    Yki-Järvinen H; Puhakainen I; Koivisto VA
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1268-77. PubMed ID: 2026747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog.
    Altszuler N; Gottlieb B; Hampshire J
    Diabetes; 1976 Feb; 25(2):116-21. PubMed ID: 1248672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.